XBiotech (XBIT) Metrics: History & Chart

XBiotech Inc.(XBIT)

Biotechnology · Austin, TX

$2.16-0.02 (-0.92%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About XBiotech Inc.

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Austin, TX

87 employees

www.xbiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sushma Shivaswamy

View full financials

Third-Party DCF Estimate (FMP)	$4.08
Price Gap vs Third-Party Estimate	+89.02%

7D Total Return	+1.40%
30D Total Return	-0.91%
YTD Total Return	-8.79%
1Y Total Return	-17.42%
3Y Total Return	-45.63%
5Y Total Return	-82.41%
10Y Total Return	-82.00%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-8.79%
2025	-39.49%
2024	-1.25%
2023	+13.96%
2022	-68.46%
2021	-18.28%
2020

CAGR TTM	-17.35%
CAGR 3Y	-18.38%
CAGR 5Y	-29.36%
CAGR 10Y	-15.76%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	1.05
PE Ratio Avg TTM	0.90
PE Ratio Avg 3Y	0.90
Current VS TTM Avg	+16.99%
Current VS 3Y Avg	+16.99%
Current VS 5Y Avg	+16.99%

All Metrics

XBIT Valuation Metrics

XBIT Stock Price Metrics

XBIT Dividend Metrics

XBIT Growth Rate Metrics

XBIT Discounted Cash Flow Metrics

XBIT Returns By Period

XBIT Yearly Returns

XBIT Average Annual Returns By Period (CAGR)

XBIT Revenue Metrics

XBIT PE Ratio Metrics

XBIT PS Ratio Metrics

XBIT PB Ratio Metrics

XBIT Price to Free Cash Flow Ratio Metrics

XBIT Debt to Equity Ratio Metrics

XBIT PEG Ratio Metrics

XBIT FCF Yield

XBIT Earnings Yield

XBIT EBITDA Yield

XBIT OCF Yield

XBIT EV/EBIT Ratio Metrics

XBIT EV/EBITDA Ratio Metrics

XBIT EV/Assets Ratio Metrics

XBIT EV/Sales Ratio Metrics

XBIT Current Ratio Metrics

XBIT Quick Ratio Metrics

XBIT ROIC Metrics

XBIT Return on Assets Metrics

XBIT Return on Equity Metrics

XBIT Net Profit Margin Metrics

XBIT Gross Profit Margin Metrics

XBIT Tax Rate Metrics

PS Ratio	599.60
PS Ratio Avg TTM	200.05
PS Ratio Avg 3Y	22.87
Current VS TTM Avg	+199.73%
Current VS 3Y Avg	+2522.06%
Current VS 5Y Avg	+2529.15%

PB Ratio	0.52
PB Ratio Avg TTM	0.49
PB Ratio Avg 3Y	0.67
Current VS TTM Avg	+5.98%
Current VS 3Y Avg	-22.19%
Current VS 5Y Avg	-24.44%

PFCF Ratio	2.61
PFCF Ratio Avg TTM	4.54
PFCF Ratio Avg 3Y	4.54
Current VS TTM Avg	-42.53%
Current VS 3Y Avg	-42.53%
Current VS 5Y Avg	-42.53%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	N/A
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	38.36%
FCF Yield Avg TTM	24.06%
FCF Yield Avg 3Y	24.06%
Current VS TTM Avg	+59.45%
Current VS 3Y Avg	+59.45%
Current VS 5Y Avg	+59.45%

Earnings Yield	95.31%
Earnings Yield Avg TTM	111.40%
Earnings Yield Avg 3Y	111.40%
Current VS TTM Avg	-14.44%
Current VS 3Y Avg	-14.44%
Current VS 5Y Avg	-14.44%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.10
Ev/Assets Ratio Avg TTM	0.17
Ev/Assets Ratio Avg 3Y	0.16
Current VS TTM Avg	-40.89%
Current VS 3Y Avg	-37.35%
Current VS 5Y Avg	-78.59%

Ev/Sales Ratio	26.07
Ev/Sales Ratio Avg TTM	4.11
Ev/Sales Ratio Avg 3Y	5.23
Current VS TTM Avg	+534.57%
Current VS 3Y Avg	+398.45%
Current VS 5Y Avg	+311.71%

Current Ratio	33.15
Current Ratio Avg TTM	34.03
Current Ratio Avg 3Y	28.02
Current VS TTM Avg	-2.57%
Current VS 3Y Avg	+18.30%
Current VS 5Y Avg	-20.29%

Quick Ratio	33.15
Quick Ratio Avg TTM	34.03
Quick Ratio Avg 3Y	28.02
Current VS TTM Avg	-2.57%
Current VS 3Y Avg	+18.30%
Current VS 5Y Avg	-20.29%

ROIC	(37.01%)
ROIC Avg 3Y	(21.18%)
ROIC Avg 5Y	(15.93%)
Current VS 3Y Avg	-74.74%
Current VS 5Y Avg	-132.29%
Current VS 10Y Avg	-44.81%

ROA	(33.77%)
ROA Avg TTM	(6.27%)
ROA Avg 3Y	(3.87%)
Current VS TTM Avg	-438.49%
Current VS 3Y Avg	-771.78%
Current VS 5Y Avg	-927.49%

ROE	(35.13%)
ROE Avg TTM	(26.21%)
ROE Avg 3Y	(18.59%)
Current VS TTM Avg	-34.03%
Current VS 3Y Avg	-88.94%
Current VS 5Y Avg	-168.77%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+100.00%

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

Tax Rate	6.77%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A